SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-22-000108
Filing Date
2022-08-08
Accepted
2022-08-08 08:01:26
Documents
81
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sesn-20220630.htm   iXBRL 10-Q 1387805
  Complete submission text file 0001485003-22-000108.txt   6911101

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20220630.xsd EX-101.SCH 58107
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sesn-20220630_cal.xml EX-101.CAL 53279
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sesn-20220630_def.xml EX-101.DEF 257105
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20220630_lab.xml EX-101.LAB 650068
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20220630_pre.xml EX-101.PRE 430487
75 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20220630_htm.xml XML 1007977
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 221142608
SIC: 2834 Pharmaceutical Preparations